Related references
Note: Only part of the references are listed.b-arrestin-mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
Takahisa Noma et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Trastuzumab: triumphs and tribulations
R. Nahta et al.
ONCOGENE (2007)
Protease-activated receptor-1 (hPar1), a survival factor eliciting tumor progression
Zaidoun Salah et al.
MOLECULAR CANCER RESEARCH (2007)
ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors
Haruhiko Ohtsu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis
Patrick Kelly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells
DR Morris et al.
CANCER RESEARCH (2006)
GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathways
S Hart et al.
BIOLOGICAL CHEMISTRY (2005)
Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach
A Lautrette et al.
NATURE MEDICINE (2005)
PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells
A Boire et al.
CELL (2005)
Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion
MA Booden et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors
AW Burgess et al.
MOLECULAR CELL (2003)
Transactivation joins multiple tracks to the ERK/MAPK cascade
R Wetzker et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Expression of the HERI-4 family of receptor tyrosine kinases in breast cancer
CJ Witton et al.
JOURNAL OF PATHOLOGY (2003)
TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells
A Gschwind et al.
EMBO JOURNAL (2003)
TACE is required for the activation of the EGFR by TGF-α in tumors
M Borrell-Pagès et al.
EMBO JOURNAL (2003)
The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors
TPJ Garrett et al.
MOLECULAR CELL (2003)
β-arrestins regulate protease-activated receptor-1 desensitization but not internalization or down-regulation
MM Paing et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
M Asakura et al.
NATURE MEDICINE (2002)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
